» Articles » PMID: 35673561

Pyroptosis in Inflammatory Diseases and Cancer

Overview
Journal Theranostics
Date 2022 Jun 8
PMID 35673561
Authors
Affiliations
Soon will be listed here.
Abstract

Pyroptosis is a lytic and inflammatory type of programmed cell death that is usually triggered by inflammasomes and executed by gasdermin proteins. The main characteristics of pyroptosis are cell swelling, membrane perforation, and the release of cell contents. In normal physiology, pyroptosis plays a critical role in host defense against pathogen infection. However, excessive pyroptosis may cause immoderate and continuous inflammatory responses that involves in the occurrence of inflammatory diseases. Attractively, as immunogenic cell death, pyroptosis can serve as a new strategy for cancer elimination by inducing pyroptotic cell death and activating intensely antitumor immunity. To make good use of this double-edged sword, the molecular mechanisms, and therapeutic implications of pyroptosis in related diseases need to be fully elucidated. In this review, we first systematically summarize the signaling pathways of pyroptosis and then present the available evidences indicating the role of pyroptosis in inflammatory diseases and cancer. Based on this, we focus on the recent progress in strategies that inhibit pyroptosis for treatment of inflammatory diseases, and those that induce pyroptosis for cancer therapy. Overall, this should shed light on future directions and provide novel ideas for using pyroptosis as a powerful tool to fight inflammatory diseases and cancer.

Citing Articles

Impdh1 was identified as a key protein promotes diabetic vasculopathy by intervention of vascular endothelial cell pyroptosis.

Xie R, Gao H, Xie H, Xie C, Li T BMC Cardiovasc Disord. 2025; 25(1):176.

PMID: 40082765 PMC: 11905600. DOI: 10.1186/s12872-025-04604-z.


From Inflammasomes to Pyroptosis: Molecular Mechanisms in Chronic Intestinal Diseases - Opportunity or Challenge?.

Fang J, Zhu W, Yu D, Zhu L, Zha H, Tang J J Inflamm Res. 2025; 18:3349-3360.

PMID: 40070928 PMC: 11895680. DOI: 10.2147/JIR.S498703.


SNS‑032 combined with decitabine induces caspase‑3/gasdermin E‑dependent pyroptosis in breast cancer cells.

Chen Y, Zhang D, Li J, Sun Y, Wang J, Xi L Oncol Lett. 2025; 29(4):202.

PMID: 40070781 PMC: 11894506. DOI: 10.3892/ol.2025.14948.


Role of oxeiptosis in disease mechanisms and therapeutic opportunities.

Bhuvaneshwari K, Harithpriya K, Ganesan K, Xu B, Ramkumar K Apoptosis. 2025; .

PMID: 40064755 DOI: 10.1007/s10495-025-02087-z.


CPCGI Alleviates Neural Damage by Modulating Microglial Pyroptosis After Traumatic Brain Injury.

Yu L, Sun L, Yu T, Guo A, Wu J, Chen J CNS Neurosci Ther. 2025; 31(3):e70322.

PMID: 40059065 PMC: 11890976. DOI: 10.1111/cns.70322.


References
1.
Chowdhury D, Lieberman J . Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol. 2008; 26:389-420. PMC: 2790083. DOI: 10.1146/annurev.immunol.26.021607.090404. View

2.
Hersh D, Monack D, Smith M, Ghori N, Falkow S, Zychlinsky A . The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A. 1999; 96(5):2396-401. PMC: 26795. DOI: 10.1073/pnas.96.5.2396. View

3.
Conos S, Chen K, De Nardo D, Hara H, Whitehead L, Nunez G . Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci U S A. 2017; 114(6):E961-E969. PMC: 5307433. DOI: 10.1073/pnas.1613305114. View

4.
Hu J, Dong Y, Ding L, Dong Y, Wu Z, Wang W . Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment. Signal Transduct Target Ther. 2019; 4:28. PMC: 6799825. DOI: 10.1038/s41392-019-0062-9. View

5.
Ruhl S, Shkarina K, Demarco B, Heilig R, Santos J, Broz P . ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018; 362(6417):956-960. DOI: 10.1126/science.aar7607. View